EUR 19.33
(1.57%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 925.5 Million | 848.96 Million | 697.66 Million | 154.97 Million |
Cost of Revenue | 716.81 Million | 669.01 Million | 558.26 Million | 117.5 Million |
Gross Profit | 208.68 Million | 179.94 Million | 139.39 Million | 37.47 Million |
Operating Expenses | 119.73 Million | 115.9 Million | 103.09 Million | 22.62 Million |
Selling, General and Administrative Expenses | 117.95 Million | 98.93 Million | 84.66 Million | 16.86 Million |
Research and Development Expenses | 21.87 Million | 18.29 Million | 18.19 Million | 5.15 Million |
Other Expenses | -20.09 Million | 1.32 Million | -234 Thousand | -609 Thousand |
Cost and Expenses | 836.54 Million | 784.91 Million | 661.36 Million | 140.13 Million |
Operating Income | 88.95 Million | 64.04 Million | 36.29 Million | 14.84 Million |
Interest Expense | 35.83 Million | 39.88 Million | 37.77 Million | 12.43 Million |
Income Tax Expense | 14.26 Million | -1.36 Million | 11.11 Million | 9.45 Million |
Earnings before Tax | 46.58 Million | 14.75 Million | 10.23 Million | -12.85 Million |
Net Income | 32.3 Million | 16.11 Million | -878 Thousand | -20.31 Million |
Earnings Per Share Basic | 0.32 | 0.16 | -0.01 | -0.20 |
Earnings Per Share Diluted | 0.32 | 0.16 | -0.01 | -0.20 |
Weighted Average Shares Outstanding | 100.95 Million | 100 Million | 100 Million | 100 Million |
Weighted Average Shares Outstanding (Diluted) | 100 Million | 100 Million | 100 Million | 100 Million |
Gross Margin | 0.23 | 0.21 | 0.20 | 0.24 |
EBIT Margin | 0.18 | 0.19 | 0.16 | 0.19 |
Profit Margin | 0.03 | 0.02 | -0.00 | -0.13 |
EBITDA | 164.91 Million | 149.25 Million | 112.23 Million | 12.78 Million |
Earnings Before Tax Margin | 0.10 | 0.08 | 0.05 | 0.10 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 272.63 Million | 237.67 Million | 272.81 Million | 925.5 Million | 242.5 Million | 216.23 Million |
Cost of Revenue | 207.89 Million | 187.67 Million | 212.74 Million | 696.84 Million | 186.99 Million | 159.95 Million |
Gross Profit | 64.73 Million | 49.99 Million | 60.07 Million | 228.65 Million | 55.51 Million | 56.28 Million |
Operating Expenses | 39.71 Million | 38.8 Million | 30.02 Million | 145.85 Million | 31.59 Million | 31.09 Million |
Selling, General and Administrative Expenses | 39.71 Million | 38.8 Million | 27.47 Million | - | 31.59 Million | 30.19 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 841 Thousand | - | -2.55 Million | -7.02 Million | - | - |
Cost and Expenses | 247.61 Million | 226.48 Million | 242.76 Million | 842.69 Million | 218.59 Million | 191.04 Million |
Operating Income | 25.02 Million | 11.18 Million | 30.05 Million | 82.8 Million | 23.91 Million | 25.19 Million |
Interest Expense | 6.61 Million | 8.79 Million | 9.64 Million | 35.83 Million | 9.93 Million | 9.25 Million |
Income Tax Expense | 6.1 Million | 6.56 Million | 5.46 Million | 14.26 Million | 4.02 Million | 5.95 Million |
Earnings before Tax | 16.39 Million | 3.79 Million | 18.9 Million | 46.58 Million | 17.12 Million | 15.93 Million |
Net Income | 10.28 Million | -2.77 Million | 13.41 Million | 32.3 Million | 13.09 Million | 9.98 Million |
Earnings Per Share Basic | 0.10 | -0.03 | 0.13 | - | 0.13 | 0.30 |
Earnings Per Share Diluted | 0.10 | -0.03 | 0.13 | - | 0.13 | 0.30 |
Weighted Average Shares Outstanding | 100 Million | 100 Million | 100 Million | 100 Million | 100 Million | 33.33 Million |
Weighted Average Shares Outstanding (Diluted) | 100 Million | 100 Million | 100 Million | 100 Million | 100 Million | 33.33 Million |
Gross Margin | 0.24 | 0.21 | 0.22 | 0.25 | 0.23 | 0.26 |
EBIT Margin | 0.16 | 0.13 | 0.18 | - | 0.10 | 0.21 |
Profit Margin | 0.04 | -0.01 | 0.05 | 0.03 | 0.05 | 0.05 |
EBITDA | 44.18 Million | 29.83 Million | 50.28 Million | - | 23.91 Million | 45.03 Million |
Earnings Before Tax Margin | 0.09 | 0.05 | 0.11 | 0.09 | 0.10 | 0.12 |
CLEDUCATE
UD2
9330
ZTCOF
ORGANICREC
UEIC